Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Tew

Showing results (1-10 of 296) with videos related to

Pageof 30
Sort By:
Computers in Healthcare|July 9, 1987
Trends in HMO/PPO administrationD Tew
Current Opinion in Pharmacology|October 14, 2009
Redox pathways in cancer drug discoveryKenneth D Tew
Seminars in Oncology|September 1, 1983
The mechanism of action of estramustineK D Tew
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|August 11, 2001
Is there a role for glyoxalase I inhibitors as antitumor drugs?Kenneth D. Tew
Pigment Cell & Melanoma Research|January 5, 2012
NrF2 ⁄Keap1 as gatekeepers of redox homeostasis – do they prevent or cause cancer?Kenneth D Tew
Current Opinion in Psychiatry|April 28, 2006
Post-hospitalization transitional care needs of depressed elderly patients: models for improvementJames D Tew
The Journal of Pharmacology and Experimental Therapeutics|December 3, 2015
Editor's NoteKenneth D Tew
Molecular Cancer Therapeutics|March 18, 2004
Small molecule inhibition of hypoxia inducible factor-1alpha: a viable therapeutic approach?Kenneth D Tew
Cancer Research|August 15, 1994
Glutathione-associated enzymes in anticancer drug resistanceK D Tew
Seminars in Oncology|December 1, 1982
Comparative cytotoxic properties of ifosfamide and cyclophosphamide in rat solid tumor and normal tissuesK D Tew
Pageof 30

Showing results (1-10 of 296) with videos related to

Sort By:
Pageof 30
Computers in Healthcare|July 9, 1987
Trends in HMO/PPO administrationD Tew
Current Opinion in Pharmacology|October 14, 2009
Redox pathways in cancer drug discoveryKenneth D Tew
Seminars in Oncology|September 1, 1983
The mechanism of action of estramustineK D Tew
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|August 11, 2001
Is there a role for glyoxalase I inhibitors as antitumor drugs?Kenneth D. Tew
Pigment Cell & Melanoma Research|January 5, 2012
NrF2 ⁄Keap1 as gatekeepers of redox homeostasis – do they prevent or cause cancer?Kenneth D Tew
Current Opinion in Psychiatry|April 28, 2006
Post-hospitalization transitional care needs of depressed elderly patients: models for improvementJames D Tew
The Journal of Pharmacology and Experimental Therapeutics|December 3, 2015
Editor's NoteKenneth D Tew
Molecular Cancer Therapeutics|March 18, 2004
Small molecule inhibition of hypoxia inducible factor-1alpha: a viable therapeutic approach?Kenneth D Tew
Cancer Research|August 15, 1994
Glutathione-associated enzymes in anticancer drug resistanceK D Tew
Seminars in Oncology|December 1, 1982
Comparative cytotoxic properties of ifosfamide and cyclophosphamide in rat solid tumor and normal tissuesK D Tew
Pageof 30